Pinned straw:
Interesting to see the Rectifier results compared with Tritium (arguably their biggest customer and as I highlighted in another post what I worry is a massive concentration risk for RFT).
Tritium share price is “in the dunny” YTD. While I know Strawman has an ASX listed small cap focus, couldn’t resist this one for Tritium (DCFC). I’m hoping that it’s just growing pains (30c share price compared with $4.01 52-week high) associated with their transition towards the ramp up of their very large (I think 4x existing capacity) USA assembly line and the taps on the market to fund the growth trajectory.
From an RFT perspective, I’m hoping they can continue to ride the DCFC revenue wave (286% yoy growth for H1 of 2023)
DISC: Hold DCFC and RFT IRL and RFT in Strawman.
@LifeCapital The other interesting note was $17m revenue from Tritium and $12m revenue from i-charging in the $32.8m total EV segment revenue implying a not insignificant $3.8m coming from other customers. Probably small scale test orders, but hopefully bodes well for new customers in the future.